Literature DB >> 23231055

Synthesis of cyclopentanyl carbocyclic 5-fluorocytosine ((-)-5-fluorocarbodine) using a facially selective hydrogenation approach.

Jong Hyun Cho1, Franck Amblard, Steven J Coats, Raymond F Schinazi.   

Abstract

An efficient synthetic route to biologically relevant (-)-5-fluorocarbodine 6 was developed. Direct coupling of N(6)-protected 5-fluorouracil 15 with cyclopentenyl intermediate 13, followed by formation of a macrocycle between the base and the carbocyclic sugar moiety, via ring-closing metathesis, allowed for a facial selective hydrogenation of the sugar double bond to give, exclusively, the desired 4'-β stereoisomer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23231055      PMCID: PMC3569026          DOI: 10.1021/jo302038d

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  21 in total

Review 1.  Palladium-assisted routes to nucleosides.

Authors:  Luigi A Agrofoglio; Isabelle Gillaizeau; Yoshio Saito
Journal:  Chem Rev       Date:  2003-05       Impact factor: 60.622

2.  New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6'-homoneplanocin A1.

Authors:  S Shuto; T Obara; Y Saito; G Andrei; R Snoeck; E De Clercq; A Matsuda
Journal:  J Med Chem       Date:  1996-06-07       Impact factor: 7.446

3.  Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine.

Authors:  Justin G Julander; Richard A Bowen; Jagadeeshwar R Rao; Craig Day; Kristiina Shafer; Donald F Smee; John D Morrey; Chung K Chu
Journal:  Antiviral Res       Date:  2008-08-15       Impact factor: 5.970

Review 4.  Abacavir.

Authors:  R H Foster; D Faulds
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

5.  Synthesis of cyclopentitols by ring-closing approaches.

Authors:  Vanya B Kurteva; Carlos A M Afonso
Journal:  Chem Rev       Date:  2009-12       Impact factor: 60.622

6.  Streptomyces citricolor nov. sp. and a new antibiotic, aristeromycin.

Authors:  T Kusaka; H Yamamoto; M Shibata; M Muroi; T Kishi
Journal:  J Antibiot (Tokyo)       Date:  1968-04       Impact factor: 2.649

Review 7.  Carbocyclic nucleosides.

Authors:  V E Marquez; M I Lim
Journal:  Med Res Rev       Date:  1986 Jan-Mar       Impact factor: 12.944

Review 8.  Carbocyclic nucleosides (carbanucleosides) as new therapeutic leads.

Authors:  Stewart W Schneller
Journal:  Curr Top Med Chem       Date:  2002-10       Impact factor: 3.295

9.  Studies on neplanocin A, new antitumor antibiotic. I. Producing organism, isolation and characterization.

Authors:  S Yaginuma; N Muto; M Tsujino; Y Sudate; M Hayashi; M Otani
Journal:  J Antibiot (Tokyo)       Date:  1981-04       Impact factor: 2.649

10.  Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus.

Authors:  G Yamanaka; T Wilson; S Innaimo; G S Bisacchi; P Egli; J K Rinehart; R Zahler; R J Colonno
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.938

View more
  2 in total

1.  Synthesis of carbocyclic nucleoside analogs with five-membered heterocyclic nucleobases.

Authors:  Jong Hyun Cho; Steven J Coats; Raymond F Schinazi
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

2.  Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives.

Authors:  Az-Eddine El Mansouri; Saida Lachhab; Ali Oubella; Mehdi Ahmad; Johan Neyts; Dirk Jochmans; Winston Chiu; Laura Vangeel; Steven De Jonghe; Hamid Morjani; Mustapha Ait Ali; Mohamed Zahouily; Yogesh S Sanghvi; Hassan B Lazrek
Journal:  J Mol Struct       Date:  2022-09-09       Impact factor: 3.841

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.